Updates matching "Remove Hurdles to Cancer Care"

Today the Senate Health, Education, Labor and Pensions Committee will markup legislation aimed at helping reduce patients’ out-of-pocket health care costs and improving public health. The Lower Health Care Costs Act would exempt patients from having to pay surprise medical bills in most circumstances.

Today the Department of Health and Human Services (HHS) issued its final rule for Medicare Part D which does not include the full range of proposed changes to drugs in the ‘six protected classes’ of cancer, epilepsy, HIV/AIDS, mental illness and organ transplants.

The American Cancer Society Cancer Action Network (ACS CAN) launched an ad campaign this week highlighting deep concerns from cancer patients and survivors over the dangerous impact that proposed changes to Medicare Part D’s six protected classes could have on their access to critical drug therapies.

A new nationwide survey of cancer patients, caregivers and doctors details the negative effects insurance utilization management policies in private insurance have had on patient care and what those policies could mean should proposed changes to Medicare’s Part D’s “six protected classes” prescription drug coverage policy go into effect.

Cancer patients, survivors and caregivers will tune into the president’s State of the Union address to see if the president will commit to strengthen the nation's health care system, support life-saving medical research and improve quality of life for patients.

On Friday the American Cancer Society Cancer Action Network (ACS CAN) along with nearly 60 other patient advocacy organizations sent a letter to the Department of Health and Human Services (HHS) about how proposed changes to Medicare Part D’s six protected classes could hurt cancer patients’ timely access to drug

Today the American Cancer Society Cancer Action Network (ACS CAN) submitted comments to the Department Health and Human Services (HHS) detailing ways in which proposed changes to Medicare Part D’s six protected classes could jeopardize cancer patients’ timely access to drug therapies.